trial · primary record
Brivaracetam
Childhood Absence Epilepsy
| Phase | Phase 3 |
|---|---|
| Status | COMPLETED |
| Sponsor | Unknown |
| Enrolment | 154 |
| Primary completion | 2026-07-07 |
| Primary endpoint | Percentage of participants who met the criteria for absence seizure freedom within 4 days prior to or during the 24-hour ambulatory electroencephalogram (EEG) at Day 14 |
| Registry ID | NCT04666610 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-30T14:45:38.133Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT04666610
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Brivaracetam · approval
- Brivaracetam · compound